You can't like your own messages.

Pfizer Inc. (PFE)
NYSE:PFE Healthcare Add to watch list

biotech
@Urbane_Gorilla http://stks.co/3z5t $CYCC $CELG $BMY $REGN $PFE #ASCO12 checklist

May. 25 at 2:51 AM
moneyinc365
$PFE & $Rfmd up huge after-hours...

May. 24 at 11:50 PM
imhobutdydd
$TARO holders sign this online petition if u agree->http://stks.co/3yVp will be sent to BOD $TEVA $EIS $AISHX $PRGO $MYL $PFE

May. 24 at 11:54 AM
BioWorld
$PFE at #PCNS: 36 TTR mutations studied and shown to be stabilized by Tafamidis

May. 24 at 11:02 AM

from Twitter
BioWorld
$PFE at #PCNS: “Expanded access is not a substitute for product approval. TTR-FAP patients in U.S. desperately need treatment option.”

May. 24 at 10:49 AM

from Twitter
BioWorld
$PFE at #PCNS: "In our program, we demonstrated that Tafamidis stabilizes TTR compared to placebo"

May. 24 at 10:47 AM

from Twitter
BioWorld
$PFE at #PCNS: Totality of evidence across secondary endpoints demonstrates consistency and ability to predict clinical benefit

May. 24 at 10:45 AM

from Twitter
BioWorld
$PFE at #PCNS: Tafamidis endpoints reasonably likely to predict clinical benefit in TTR-FAD

May. 24 at 10:43 AM

from Twitter
WallStProphet
NYSE: "Sell" signal generated for the following issue: Pfizer,Inc., $PFE, sell @ market ($22.03) 1st target $20.93...

May. 24 at 9:54 AM

from Twitter
4

EPS_MomentuM
Next week should see surge in biotechs ahead of ASCO presentations 1st week in June. $PFE, $MRK, $VVUS

May. 24 at 9:43 AM
BioWorld
$PFE at #PCNS: This is the first interventional trial in TTR-FAP. There are no validated endpoints, clinical assessment tools.

May. 24 at 9:40 AM

from Twitter
BioWorld
$PFE at #PCNS: No treatment exists for TTR-FAP patients not eligible for liver transplants or who don’t respond to transplant.

May. 24 at 9:27 AM

from Twitter
BioWorld
#PCNS: $PFE plans a confirmatory efficacy trial for tafamidis. Would like to do it post-approval so patients have access to drug.

May. 24 at 9:20 AM

from Twitter
BioWorld
#PCNS meeting: $PFE is committed to developing tafamidis, either with accelerated approval or on traditional path.

May. 24 at 9:17 AM

from Twitter
moneyinc365
$pfe $Nok and others way down. But, my stock of the month $peix shines with 4% gain. Up after hours too! Clearly a great opportunity.

May. 23 at 10:10 PM

Follow PFE on StockTwits!

Join StockTwits and follow your favorite tickers. Get a personalized stream of news, charts, and ideas.

22.22 +0.13 (0.59%) last updated 4:46 PM EDT May 24

Follow 531 Followers

Chart Type: Daily | Weekly | Monthly

Price
Fund

PFE Related Tickers

Company	Msg Trend	Last Price
$TEVA Teva Pharmaceutica...	-	38.69 +0.11 (0.29%)
$MYL Mylan, Inc.	N/C	21.28 +0.39 (1.87%)
$GSK GlaxoSmithKline plc	-	44.24 +0.34 (0.77%)
$ABT Abbott Laboratories	-	62.42 +1.05 (1.71%)
$PRGO Perrigo Co.	N/C	102.92 +1.70 (1.68%)

Prev 1 2 Next

Pfizer Inc. (PFE)
NYSE:PFE Healthcare Add to watch list

Add Twitter Connection

Add Facebook Connection

Add LinkedIn Connection

Follow PFE on StockTwits!

PFE Related Tickers

PFE on Yahoo! Finance

PFE Chart.ly Charts

Pfizer Inc. (PFE) NYSE:PFE Healthcare Add to watch list

Add Twitter Connection

Add Facebook Connection

Add LinkedIn Connection

Follow PFE on StockTwits!

PFE Related Tickers

PFE on Yahoo! Finance

PFE Chart.ly Charts

Sign in to StockTwits X

Sign in

Sign up using:

Sign in to StockTwits X

Sign up X

Join StockTwits

Sign up using:

Pfizer Inc. (PFE)
NYSE:PFE Healthcare Add to watch list

Sign up
using:

Sign up
using: